Demetris Papamichael Selected Research

Demetris Papamichael Research Topics

Disease

11	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2009
7	Neoplasms (Cancer) 01/2021 - 06/2008
4	Colonic Neoplasms (Colon Cancer) 11/2016 - 02/2014
3	Stomach Neoplasms (Stomach Cancer) 03/2022 - 01/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2016
2	Neoplasm Metastasis (Metastasis) 02/2013 - 12/2009
2	Nasopharyngeal Carcinoma 06/2008 - 04/2005
1	Disease Progression 01/2021
1	Obesity 01/2021
1	Frailty 11/2018
1	Rectal Neoplasms (Rectal Cancer) 04/2016
1	Adenocarcinoma 01/2016
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2014
1	Exanthema (Rash) 10/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2011
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2008
1	Epstein-Barr Virus Infections 06/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2008
1	Infectious Mononucleosis (Glandular Fever) 06/2008

Drug/Important Bio-Agent (IBA)

6	Cetuximab (Erbitux)FDA Link 06/2015 - 12/2009
3	Biomarkers (Surrogate Marker)IBA 03/2017 - 02/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 05/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 12/2015
2	Leucovorin (Folinic Acid)FDA Link 01/2018 - 12/2015
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 12/2015
2	IMM-101IBA 10/2016 - 01/2016
2	Gemcitabine FDA Link 10/2016 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 06/2008
2	Messenger RNA (mRNA)IBA 12/2013 - 02/2013
2	Monoclonal AntibodiesIBA 12/2013 - 02/2013
2	ErbB Receptors (EGF Receptor)IBA 08/2010 - 12/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Biological ProductsIBA 01/2020
1	ElementsIBA 11/2018
1	velourIBA 01/2018
1	afliberceptIBA 01/2018
1	Chromogranin AIBA 03/2017
1	Sodium Glutamate (Accent)IBA 11/2016
1	Dihydrotachysterol (AT 10)IBA 12/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014
1	Bevacizumab (Avastin)FDA Link 02/2014
1	Tumor Biomarkers (Tumor Markers)IBA 02/2014
1	Neutralizing AntibodiesIBA 02/2014
1	Epithelial Cell Adhesion MoleculeIBA 01/2014
1	EpiregulinIBA 12/2013
1	human ERBB2 proteinIBA 12/2013
1	Carrier Proteins (Binding Protein)IBA 12/2013
1	Formaldehyde (Formol)FDA Link 12/2013
1	Insulin (Novolin)FDA Link 12/2013
1	ParaffinIBA 12/2013
1	Growth Factor ReceptorsIBA 12/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013
1	Ephrin-A2 (Ephrin A2)IBA 12/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013
1	AmphiregulinIBA 12/2013
1	Codon (Codons)IBA 02/2013
1	LigandsIBA 02/2013
1	Gefitinib (Iressa)FDA Link 10/2011
1	Tyrosine Kinase InhibitorsIBA 10/2011
1	Docetaxel (Taxotere)FDA Link 05/2011
1	PlatinumIBA 05/2011
1	AntibodiesIBA 08/2010
1	Panitumumab (Vectibix)FDA Link 08/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2008
1	HLA-DRB1 Chains (HLA DRB1)IBA 06/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2005
1	Cisplatin (Platino)FDA LinkGeneric 04/2005
1	Epirubicin (Ellence)FDA LinkGeneric 04/2005

Therapy/Procedure

9	Therapeutics 01/2021 - 12/2009
8	Drug Therapy (Chemotherapy) 03/2022 - 07/2010
4	Adjuvant Chemotherapy 01/2020 - 12/2015
2	Induction Chemotherapy 01/2021 - 04/2005
2	Radiotherapy 04/2016 - 04/2005
1	Metastasectomy 02/2014
1	Ligation 02/2014